Loss of CEACAM1 in hepatocytes causes hepatic fibrosis
dc.contributor.author | Zaidi, S | |
dc.contributor.author | Asalla, S | |
dc.contributor.author | Muturi, HT | |
dc.contributor.author | Russo, L | |
dc.contributor.author | Abdolahipour, R | |
dc.contributor.author | Belew, GD | |
dc.contributor.author | Iglesias, MB | |
dc.contributor.author | Feraudo, M | |
dc.contributor.author | Leon, L | |
dc.contributor.author | Kuo, E | |
dc.contributor.author | Liu, X | |
dc.contributor.author | Kumarasamy, S | |
dc.contributor.author | Ghadieh, HE | |
dc.contributor.author | Gatto-Weis, C | |
dc.contributor.author | Zarrinpar, A | |
dc.contributor.author | Duarte, S | |
dc.contributor.author | Najjar, SM | |
dc.coverage.spatial | England | |
dc.date.accessioned | 2024-06-26T00:06:31Z | |
dc.date.available | 2024-06-26T00:06:31Z | |
dc.date.issued | 2024-07-01 | |
dc.identifier.issn | 0014-2972 | |
dc.identifier.issn | 1365-2362 | |
dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pubmed/38381498 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/193958 | en |
dc.description.abstract | Background: The role of insulin resistance in hepatic fibrosis in Metabolic dysfunction-Associated SteatoHepatitis (MASH) remains unclear. Carcinoembryonic Antigen-related Cell Adhesion Molecule1 protein (CEACAM1) promotes insulin clearance to maintain insulin sensitivity and repress de novo lipogenesis, as bolstered by the development of insulin resistance and steatohepatitis in AlbuminCre + Cc1fl/fl mice with liver-specific mouse gene encoding CEACAM1 protein (Ceacam1) deletion. We herein investigated whether these mice also developed hepatic fibrosis and whether hepatic CEACAM1 is reduced in patients with MASH at different fibrosis stages. Methods: AlbuminCre + Cc1fl/fl mice were fed a regular or a high-fat diet before their insulin metabolism and action were assessed during IPGTT, and their livers excised for histochemical, immunohistochemical and Western blot analysis. Sirius red staining was used to assess fibrosis, and media transfer was employed to examine whether mutant hepatocytes activated hepatic stellate cells (HSCs). Hepatic CEACAM1 protein levels in patients with varying disease stages were assessed by ELISA. Results: Hepatocytic deletion of Ceacam1 caused hyperinsulinemia-driven insulin resistance emanating from reduced hepatic insulin clearance. AlbuminCre + Cc1fl/fl livers showed inflammation, fibrosis and hepatic injury, with more advanced bridging and chicken-wire hepatic fibrosis under high-fat conditions. Media transferred from hepatocytes isolated from mutant mice activated control HSCs, likely owing to their elevated endothelin1 content. Interestingly, hepatic CEACAM1 levels were lower in the livers of patients with MASH and declined gradually with advanced fibrosis stage. Conclusions: Hepatic CEACAM1 levels declined with progression of MASH in humans. The phenotype of AlbuminCre + Cc1fl/fl mice assigned a key role to CEACAM1 loss from hepatocytes in hepatic fibrosis independently of other liver cells. | |
dc.format.medium | Print-Electronic | |
dc.language | eng | |
dc.publisher | Wiley | |
dc.rights | Licence for published version: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | fibrosis stage | |
dc.subject | hepatic stellate cells | |
dc.subject | insulin extraction | |
dc.subject | insulin resistance | |
dc.subject | steatohepatitis | |
dc.subject | Animals | |
dc.subject | Hepatocytes | |
dc.subject | Liver Cirrhosis | |
dc.subject | Mice | |
dc.subject | Humans | |
dc.subject | Insulin Resistance | |
dc.subject | Diet, High-Fat | |
dc.subject | Carcinoembryonic Antigen | |
dc.subject | Male | |
dc.subject | Hepatic Stellate Cells | |
dc.subject | Cell Adhesion Molecules | |
dc.subject | Hyperinsulinism | |
dc.subject | Fatty Liver | |
dc.subject | Antigens, CD | |
dc.subject | Non-alcoholic Fatty Liver Disease | |
dc.title | Loss of CEACAM1 in hepatocytes causes hepatic fibrosis | |
dc.type | Article | |
dc.identifier.pmid | 38381498 | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/193958/2/Loss of CEACAM1 in hepatocytes causes hepatic fibrosis.pdf | |
dc.identifier.doi | 10.1111/eci.14177 | |
dc.identifier.doi | https://dx.doi.org/10.7302/23440 | |
dc.identifier.source | European Journal of Clinical Investigation | |
dc.description.version | Accepted version | |
dc.date.updated | 2024-06-26T00:05:46Z | |
dc.identifier.orcid | 0000-0001-6209-8902 | |
dc.description.filedescription | Description of Loss of CEACAM1 in hepatocytes causes hepatic fibrosis.pdf : Published version | |
dc.identifier.volume | 54 | |
dc.identifier.issue | 7 | |
dc.identifier.startpage | e14177 | |
dc.identifier.name-orcid | Zaidi, S | |
dc.identifier.name-orcid | Asalla, S | |
dc.identifier.name-orcid | Muturi, HT | |
dc.identifier.name-orcid | Russo, L | |
dc.identifier.name-orcid | Abdolahipour, R | |
dc.identifier.name-orcid | Belew, GD | |
dc.identifier.name-orcid | Iglesias, MB | |
dc.identifier.name-orcid | Feraudo, M | |
dc.identifier.name-orcid | Leon, L | |
dc.identifier.name-orcid | Kuo, E | |
dc.identifier.name-orcid | Liu, X | |
dc.identifier.name-orcid | Kumarasamy, S | |
dc.identifier.name-orcid | Ghadieh, HE | |
dc.identifier.name-orcid | Gatto-Weis, C | |
dc.identifier.name-orcid | Zarrinpar, A | |
dc.identifier.name-orcid | Duarte, S | |
dc.identifier.name-orcid | Najjar, SM; 0000-0001-6209-8902 | |
dc.working.doi | 10.7302/23440 | en |
dc.owningcollname | Pediatrics and Communicable Diseases, Department of |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.